Windsor Group LTD grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,914 shares of the healthcare conglomerate’s stock after purchasing an additional 81 shares during the quarter. Windsor Group LTD’s holdings in UnitedHealth Group were worth $1,723,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in UNH. Prestige Wealth Management Group LLC raised its holdings in UnitedHealth Group by 20.3% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 1,829 shares of the healthcare conglomerate’s stock worth $570,000 after purchasing an additional 309 shares during the last quarter. Cypress Asset Management Inc. TX raised its holdings in UnitedHealth Group by 0.8% during the 3rd quarter. Cypress Asset Management Inc. TX now owns 9,216 shares of the healthcare conglomerate’s stock worth $2,873,000 after purchasing an additional 76 shares during the last quarter. Clear Harbor Asset Management LLC raised its holdings in UnitedHealth Group by 5.2% during the 3rd quarter. Clear Harbor Asset Management LLC now owns 7,653 shares of the healthcare conglomerate’s stock worth $2,386,000 after purchasing an additional 381 shares during the last quarter. Landsberg Bennett & Dubbaneh LLC raised its holdings in UnitedHealth Group by 2.4% during the 3rd quarter. Landsberg Bennett & Dubbaneh LLC now owns 15,833 shares of the healthcare conglomerate’s stock worth $4,816,000 after purchasing an additional 377 shares during the last quarter. Finally, Steel Peak Wealth Management LLC raised its holdings in UnitedHealth Group by 29.8% during the 3rd quarter. Steel Peak Wealth Management LLC now owns 959 shares of the healthcare conglomerate’s stock worth $299,000 after purchasing an additional 220 shares during the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.
Several analysts have recently weighed in on UNH shares. Stephens lifted their price objective on shares of UnitedHealth Group from $355.00 to $380.00 and gave the company an “overweight” rating in a research note on Wednesday, December 2nd. Cantor Fitzgerald lifted their price objective on shares of UnitedHealth Group from $360.00 to $375.00 and gave the company an “overweight” rating in a research note on Wednesday, December 2nd. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $360.00 to $430.00 in a research note on Wednesday, December 2nd. Credit Suisse Group lifted their price objective on shares of UnitedHealth Group from $355.00 to $395.00 and gave the company an “average” rating in a research note on Thursday, November 5th. Finally, Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $371.00 to $454.00 and gave the company an “overweight” rating in a research note on Wednesday, December 2nd. Five investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $387.82.
NYSE UNH traded up $0.94 during mid-day trading on Tuesday, hitting $328.58. The company’s stock had a trading volume of 118,155 shares, compared to its average volume of 3,453,442. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $311.76 billion, a price-to-earnings ratio of 18.82, a PEG ratio of 1.55 and a beta of 0.74. The company’s 50 day simple moving average is $341.25 and its 200 day simple moving average is $330.10. UnitedHealth Group Incorporated has a twelve month low of $187.72 and a twelve month high of $367.95.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 19th. The healthcare conglomerate reported $2.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.39 by $0.13. The firm had revenue of $65.47 billion for the quarter, compared to the consensus estimate of $64.98 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.90 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Featured Article: Understanding Price to Earnings Ratio (PE)
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.